Ad is loading...
CTMX
Price
$0.91
Change
-$0.09 (-9.00%)
Updated
Nov 15 closing price
100 days until earnings call
TECH
Price
$67.57
Change
-$4.97 (-6.85%)
Updated
Nov 15 closing price
78 days until earnings call
Ad is loading...

CTMX vs TECH

Header iconCTMX vs TECH Comparison
Open Charts CTMX vs TECHBanner chart's image
CytomX Therapeutics
Price$0.91
Change-$0.09 (-9.00%)
Volume$1.28M
CapitalizationN/A
Bio-Techne
Price$67.57
Change-$4.97 (-6.85%)
Volume$2.45M
CapitalizationN/A
CTMX vs TECH Comparison Chart
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CTMX vs. TECH commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Sell and TECH is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CTMX: $0.91 vs. TECH: $67.57)
Brand notoriety: CTMX and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 150% vs. TECH: 274%
Market capitalization -- CTMX: $71.22M vs. TECH: $10.74B
CTMX [@Biotechnology] is valued at $71.22M. TECH’s [@Biotechnology] market capitalization is $10.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 2 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 2 green, 3 red.
According to our system of comparison, TECH is a better buy in the long-term than CTMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 4 TA indicator(s) are bullish while TECH’s TA Score has 5 bullish TA indicator(s).

  • CTMX’s TA Score: 4 bullish, 4 bearish.
  • TECH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CTMX and TECH are a good buy in the short-term.

Price Growth

CTMX (@Biotechnology) experienced а -16.51% price change this week, while TECH (@Biotechnology) price change was -11.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

CTMX is expected to report earnings on Feb 26, 2025.

TECH is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($10.7B) has a higher market cap than CTMX($71.2M). TECH has higher P/E ratio than CTMX: TECH (71.13) vs CTMX (5.69). TECH YTD gains are higher at: -12.051 vs. CTMX (-41.290). TECH has higher annual earnings (EBITDA): 301M vs. CTMX (7.62M). CTMX has less debt than TECH: CTMX (11.7M) vs TECH (420M). TECH has higher revenues than CTMX: TECH (1.17B) vs CTMX (120M).
CTMXTECHCTMX / TECH
Capitalization71.2M10.7B1%
EBITDA7.62M301M3%
Gain YTD-41.290-12.051343%
P/E Ratio5.6971.138%
Revenue120M1.17B10%
Total Cash137MN/A-
Total Debt11.7M420M3%
FUNDAMENTALS RATINGS
CTMX vs TECH: Fundamental Ratings
CTMX
TECH
OUTLOOK RATING
1..100
6077
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
9780
PRICE GROWTH RATING
1..100
9061
P/E GROWTH RATING
1..100
9117
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is somewhat better than the same rating for CTMX (55). This means that TECH’s stock grew somewhat faster than CTMX’s over the last 12 months.

TECH's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as CTMX (100). This means that TECH’s stock grew similarly to CTMX’s over the last 12 months.

TECH's SMR Rating (80) in the Biotechnology industry is in the same range as CTMX (97). This means that TECH’s stock grew similarly to CTMX’s over the last 12 months.

TECH's Price Growth Rating (61) in the Biotechnology industry is in the same range as CTMX (90). This means that TECH’s stock grew similarly to CTMX’s over the last 12 months.

TECH's P/E Growth Rating (17) in the Biotechnology industry is significantly better than the same rating for CTMX (91). This means that TECH’s stock grew significantly faster than CTMX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTMXTECH
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
56%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 13 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
67%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Ad is loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HIBS19.741.07
+5.73%
Direxion Daily S&P 500® Hi Bt Br 3X ETF
DFAR24.620.06
+0.24%
Dimensional US Real Estate ETF
FEMS38.15-0.02
-0.07%
First Trust Emerg Mkts SC AlphaDEX® ETF
TLT90.08-0.24
-0.27%
iShares 20+ Year Treasury Bond ETF
AAPU34.92-1.02
-2.84%
Direxion Daily AAPL Bull 2X Shares

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-9.00%
MLEC - CTMX
42%
Loosely correlated
+0.12%
BCAB - CTMX
40%
Loosely correlated
-8.77%
PYXS - CTMX
39%
Loosely correlated
-2.10%
TECH - CTMX
39%
Loosely correlated
-6.85%
CRBU - CTMX
37%
Loosely correlated
-4.78%
More